We updated several “interim” NIAID Paylines and changed the status of some others to “final” for fiscal year 2024: niaid.nih.gov/grants-contrac…

Join Us in Palermo on May 23-24 for a meeting on Infections in Lung Transplant. Hybrid also!
subscribe: odem.collage-spa.it/app/registrati…
more info: collage-spa.it/wp-content/upl…

A really important thread on the #H5N1 #birdflu outbreak in cows. Well worth a read.

1⃣ Pay level revision for NRSA recipients is a 1st step toward reaffirming the value & progressing toward appropriate compensation for #NIH ’s pre- and postdoctoral scholars. go.nih.gov/Jenmy0T

🤩WHO'S GETTING EXCITED FOR #IDinAdults2024 ?

➡️id.hmscme.com

The CDC is actually recommending full PPE for farm workers to prevent infections of H5N1. They also acknowledge the increased risk of more transmission to people and say they would change the risk assessment if person to person transmission were sustained but not if sporadic.

🚨Pioneering work on HHV-6B by Joshua Hill, MD in HCT and CAR-T settings. Thanks for moving the field forward! #bmtsm #CARTcell #HHV6 🦠 Erika Kampouri ASTCT Blood Journal Nature Communications Michael Ison, MD MS Dr Roy Chemaly Jessica Little, MD

nature.com/articles/s4146…

ashpublications.org/blood/article/…

As baseball season begins, JAMA presents this double-header:
INSPIRE Pneumonia & INSPIRE UTI, a pair of transformative trials using CPOE prompts to create patient-specific MDRO risk estimates to reduce empiric extended-spectrum antibiotics #SHEASpring2024

'Longitudinal outcomes of COVID-19 in solid organ transplant recipients from 2020 to 2023' by Solera et al

doi.org/10.1016/j.ajt.…

New research: Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019

thelancet.com/journals/lanin…

For those in ID who treat patients receiving ECMO, I highly recommend this EuroELSO webinar that came out last week. A succinct review of best practices and practical issues

m.youtube.com/watch?v=VKvqkn…

Jordi Riera

Great to see we have a low rate of post-transplant SSI with amox/clav prophylaxis

Did you know it's Blue & Green Day? It is our privilege to care for transplant patients. #DonateLife #BlueGreenDay . Register to become an #OrganDonor #SaveLives #DukeID #DukeTxID #GiftofLife #IDTwitter

Building evidence presented at #ISHLT2024 by Northwestern Medicine Hannah Kleinboeker, PharmD that

👉letermovir should be used first line for CMV prophylaxis in #lungtransplant recipients.

Compared with valganciclovir:
⬇️ leukopenia
↔️ in #CMV breakthrough

Needs #RCT

One last call - have ideas for sessions focused on IC Hosts at ESCMID Global 2025/ECCMID 2025? Please submit them in the link in the Tweet below.

The ESCMID Study Group for Infections in Compromised Host (ESGICH) has a number of opportunities to engage with our leadership. Come hear about:

Recently completed survey of IC Host-ID members
Proposed Webinars
In Person Meeting Opportunities
Opportunities for research

ESGICH (the ESCMID Study Group for Infections in Compromised Host) is awarding 4 trainee and young investigators awards. Congratulations!!

Congratulations to Tori Hall who will presenting in Hall C on 29 April 11am-12pm.